| Date Filed | Type | Description |
| 08/09/2023 |
4
| Lombardi Ronald M. (CEO) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Sold 22,249 shares
@ $64.97, valued at
$1.4M
Sold 3,608 shares
@ $65.99, valued at
$238.1k
Sold 5,052 shares
@ $66.99, valued at
$338.4k
Sold 1,891 shares
@ $67.95, valued at
$128.5k
Exercised 32,800 options to buy
@ $33.5, valued at
$1.1M
|
|
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| ZIER DAWN M. (Director) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 2,295 shares
@ $0 |
|
| 08/03/2023 |
4
| RICCIARDI NATALE S (Director) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 2,295 shares
@ $0 |
|
| 08/03/2023 |
4
| HOPKINS SHEILA (Director) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 2,295 shares
@ $0 |
|
| 08/03/2023 |
4
| DArecca James (Director) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 2,295 shares
@ $0 |
|
| 08/03/2023 |
4
| Clark Celeste A. (Director) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 2,295 shares
@ $0 |
|
| 08/03/2023 |
4
| BYOM JOHN E (Director) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 2,295 shares
@ $0 |
|
| 08/03/2023 |
3
| DArecca James (Director) has filed a Form 3 on Prestige Consumer Healthcare Inc. |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 06/29/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 06/29/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/26/2023 |
4
| Sacco Christine (CFO) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Sold 11,283 shares
@ $60.07, valued at
$677.8k
Sold 25,746 shares
@ $60.07, valued at
$1.5M
Sold 18,265 shares
@ $60.07, valued at
$1.1M
Exercised 11,283 options to buy
@ $56.11, valued at
$633.1k
Exercised 25,746 options to buy
@ $47.39, valued at
$1.2M
|
|
| 05/24/2023 |
4/A
| Mekhail Adel (EVP, Marketing & Sales) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Sold 10,000 shares
@ $60, valued at
$600k
Sold 7,194 shares
@ $60.65, valued at
$436.3k
Exercised 10,000 options to buy
@ $30.19, valued at
$301.9k
Exercised 7,194 options to buy
@ $30.19, valued at
$217.2k
|
|
| 05/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
4
| Fritz Mary Beth (SVP Quality & Regulatory) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Sold 8,154 shares
@ $58.8, valued at
$479.5k
Exercised 8,154 options to buy
@ $29.46, valued at
$240.2k
|
|
| 05/08/2023 |
4
| Zerillo Jeffrey (Senior VP Operations) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 4,063 shares
@ $0
Paid exercise price by delivering 2,036 shares
@ $62.02, valued at
$126.3k
Paid exercise price by delivering 446 shares
@ $62.02, valued at
$27.7k
|
|
| 05/08/2023 |
4
| Sacco Christine (CFO) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 9,968 shares
@ $0
Paid exercise price by delivering 5,089 shares
@ $62.02, valued at
$315.6k
Paid exercise price by delivering 1,114 shares
@ $62.02, valued at
$69.1k
|
|
| 05/08/2023 |
4
| P'Pool William (SVP, GC & Corp Secretary) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 5,967 shares
@ $0
Paid exercise price by delivering 3,166 shares
@ $62.02, valued at
$196.4k
Paid exercise price by delivering 694 shares
@ $62.02, valued at
$43k
|
|
| 05/08/2023 |
4
| Mekhail Adel (EVP, Marketing & Sales) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 5,587 shares
@ $0
Paid exercise price by delivering 2,199 shares
@ $62.02, valued at
$136.4k
Paid exercise price by delivering 482 shares
@ $62.02, valued at
$29.9k
|
|
| 05/08/2023 |
4
| Lombardi Ronald M. (CEO) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 87,854 shares
@ $0
Paid exercise price by delivering 44,850 shares
@ $62.02, valued at
$2.8M
Paid exercise price by delivering 3,273 shares
@ $62.02, valued at
$203k
|
|
| 05/08/2023 |
4
| Fritz Mary Beth (Senior VP Quality & Regulatory) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 3,364 shares
@ $0
Paid exercise price by delivering 1,686 shares
@ $62.02, valued at
$104.6k
Paid exercise price by delivering 370 shares
@ $62.02, valued at
$22.9k
|
|
| 05/05/2023 |
4
| P'Pool William (SVP, GC & Corp Secretary) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Paid exercise price by delivering 663 shares
@ $61.25, valued at
$40.6k
|
|
| 05/05/2023 |
4
| Fritz Mary Beth (SVP Quality & Regulatory) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Paid exercise price by delivering 384 shares
@ $61.25, valued at
$23.5k
|
|
| 05/05/2023 |
4
| Zerillo Jeffrey (Senior VP Operations) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Paid exercise price by delivering 423 shares
@ $61.25, valued at
$25.9k
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Mekhail Adel (EVP, Marketing & Sales) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Paid exercise price by delivering 469 shares
@ $61.25, valued at
$28.7k
|
|
| 05/05/2023 |
4
| Lombardi Ronald M. (CEO) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Paid exercise price by delivering 3,167 shares
@ $61.25, valued at
$194k
|
|
| 05/05/2023 |
10-K
| Annual Report for the period ended March 31, 2023 |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|